Connect with us

Featured

Premier Health Is All About Healthy Shareholder Communication

Daniel Chase

Published

on

A company is only as successful as its understanding and execution of corporate communications, and on Wednesday, Premier Health Group Inc. took a major step in assuring the effectiveness of their communications. The innovative health care company, based in Vancouver, Canada, has worked tirelessly over the years to develop “innovative health care approaches that combine human skill based expertise with emerging technologies,” and in hopes of communicating these strategic aspirations to the community, Premier Health retained an arm’s length corporate communication firm, Midam Ventures, LLC (Midam). As for the details of this momentous collaboration, per the official press release, effective October 1, 2018, Midam will be paid a US$100,000 cash retainer and 500,000 common shares for its services. The common shares are subject to a voluntary restriction on trading for a period of 6 months from the date of issue. 

Premier Health Group (PHGI) has been on the cutting-edge of the health care experience for quite some time now, and recently released a major corporate update detailing how they plan to take their approaches to its fullest potential.

 In a press release detailing their most recent corporate revisions, Premier Health announced that, in August, they successfully acquired HealthVue Medical Clinics (HealthVue). Premier Health had been looking to get their foot in the doctor’s office door and this acquisition allowed them to instantaneously have access to the primary care market. HealthVue, based in the Greater Vancouver Area, consists of four “fully integrated, paperless and electronic medical record-based medical clinics with a 10-year history, 22 healthcare professionals and over 100,000 active patients.”

Premier Health, as a result of their acquisition of HealthVue, is making significant headway in terms of technological developments for the betterment of the healthcare experience. HealthVue has reportedly been working on telemedicine technology for their patients, and the new tech has been very well received. 

“Patients have found that connecting with their healthcare professional from the convenience of their work or home to be extremely revolutionary, so much so that many patients in the pilot used the service repeatedly”

Dr. Essam Hamza, CEO of Premier Health

In addition to their valuable and insightful acquisition of HealthVue, Premier Health just completed a CAD $3.55 million in financing in August 2018, with $1 million of that money being used for the HealthVue acquisition. Per the press release, the Company claims they have “no debt and are well capitalized to strategically acquire additional clinics” in the coming months. With all of these lucrative corporate developments, it was only natural for Premier Health to seek out a communications firm with an impeccable track-record to publicize their advancements. 

Premier Health Group, in partnership with Midam Ventures, LCC (Midam) is launching a strong shareholder communications initiative, “designed to provide improved visibility into the company’s current and planned operations,” according to a press release sent out on Wednesday. This initiative was motivated by the Company’s determination to be as transparent as possible with its stakeholders and active patients. 

The new communications program, conceptualized by Midam,  will provide much-needed updates to the Company’s website and investor relations portal, as well as building out an “active blog with articles provided by in-house contributors,” coupled with a cohesive social media strategy. 

For a major player like Premier Health to be going to such great lengths to provide a best-in-market experience for their health care patients is astounding. The Company, in their mission statement, says that they will “Set the gold standard for services in locations of interest worldwide,” and, in retainment of Midam Ventures and enactment of this innovate and effective communication initiative, the Company is leaving other healthcare providers in the dust. 

Continue Reading
Click to comment

Biotechnology

2 Biotech Stocks Turning Heads After Key Developments This Quarter

Joe Samuel

Published

on

biotech stocks to watch today

There are very few sectors in the stock market that have consistently produced winning trades. You might be able to count such sectors on one hand. Biotech is certainly among those sectors due to the emergence of highly innovative companies. These firms tend to create new avenues of creation to address unmet medical needs.

There are plenty of promising companies in the sector but it is necessary for an investor to do research thoroughly. It makes finding the best biotech stocks a bit easier. Though no one’s guaranteed a win, sifting out bad stocks is the key. One must watch the market closely to come across promising biotech stocks. Here is a look at two biotech stocks that are worth watching.

Biotech Stocks To Watch: Moleculin Biotech (MBRX)

The first biotech stock to consider is that of Moleculin Biotech Inc (NASDAQ:MBRX), which made some gains on Wednesday on the back of positive interim results for one of its products. The company, which is involved in manufacturing medicines meant for extremely resistant tumors, released data with regards to its acute myeloid leukaemia medicine annamycin.

top biotech stocks to buy

Moleculin revealed highly positive interim data from the Phase ½ clinical study of the medicine and naturally, it has resulted in a lot of excitement in the market with regards to the stock. The stock rose by as much as 2% on the back of the news in yesterday’s trading session. It is one of the key biotech stocks to keep an eye on over the coming days.

Biotech Stocks To Watch: Eyepoint Pharmaceuticals (EYPT)

The other biotech stock that has recorded impressive gains on the market today is the Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT) stock. On Wednesday, the company announced an important deal with regard to dexamethasone intraocular suspension 9% (DEXYCU). Eyepoint announced that it has managed to reach an agreement with one of the biggest players in the U.S. integrated delivery systems.

[Read More] 3 Pharma Stocks To Watch In December 2019

The deal is for two years and the other party is going to offer DEXYCU in its aforesaid systems. It is a major boost for Eyepoint and it has resulted in 5% to close at $1.54 in Wednesday’s trading session.

best biotech stocks to watch today

Continue Reading

Featured

Stock Price Newsletter – December 6, 2019

Joe Samuel

Published

on

stock price newsletter

2 Biotech Stocks to Watch As The Sector Hits New High

The biotech sector has thrown plenty of winners over the course of the last decade or so and if experts are to be believed then it is going to continued to do so for the foreseeable future. Great advancements are being made in the biotech industry and many companies are working on a highly advanced product.

Continue Reading


Is It Time To Buy Or Sell Netflix; Streaming Wars Heat Up

The streaming wars have commenced this month with the launch of Disney Plus and Apple TV+. Many more services are going to be launched over the coming months and the sole purpose of these services is to topple the biggest name in the streaming services, Netflix Inc (NASDAQ:NFLX). The streaming giant has had a hard time this year, due to disappointing subscriber growth.

Click To Read More


Is ROKU Stock a Buy Or Hold on Disney, Apple & Streaming TV Growth?

The stock suffered a slump following its Q3 2019 financial results but since then it has regained much of the losses. While it is true that the losses widened from the year-ago period, experts believe that Roku is a stock that could have long term growth potential.

See For Yourself

Continue Reading

Biotechnology

2 Biotech Stocks to Watch As The Sector Hits New High

Joe Samuel

Published

on

best biotechnology stocks to buy sell

The biotech sector has thrown plenty of winners over the course of the last decade or so and if experts are to be believed then it is going to continued to do so for the foreseeable future. Great advancements are being made in the biotech industry and many companies are working on a highly advanced product.

In such a situation, it is imperative for an intelligent investor to look for companies worth investing in. One should watch the latest developments in the sector and track specific companies closely. Here is a look at two biotech stocks that are worth watching.

Neoleukin Therapeutics

top biotech stocks to watch list

The first biotech stock to watch is that of Neoleukin Therapeutics Inc (NLTX), which has managed to gain significantly over the past two weeks. On November 13, the company released its third-quarter results and since then it has rocketed by as much as 75%. The Canadian company made a loss of $59.1 million in the quarter, which worked out to $2.26 per share.

The company is a biopharmaceutical company that is involved in immunotherapies using de novo protein design technology. The company’s lead product candidate is NL-201, which is an amalgamation of both IL-2 and IL-15 and helps in removing alpha receptor binding.

Verastem

healthcare stocks to buy now

The other biotech stock that is worth watching is Verastem Inc (NASDAQ:VSTM). It made significant gains over the past week. On Monday, the company announced that it has submitted a Marketing Authorization Application for its product COPIKTRA to the European Medicines Agency.

COPIKTRA is a phosphoinositide 3-kinase. It’s meant for patients suffering from refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and relapsed or refractory follicular lymphoma (FL).

The company is seeking approval for the same in the European market. Verastem stated that it has seen significant improvement in patients who used the product. The stock rocketed by as much as 60% after the news broke and remains one of the stocks to watch this week.

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


Privacy Policy

We keep all user information pricate & promise to never spam.*

Stock Price Free Text List

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com